CFDA Issues Warning Against Allopurinol Gout Drug Over Side Effects
This article was originally published in PharmAsia News
Executive Summary
The China FDA issued a warning to the public against taking the allopurinol drug for treating gout, developed in the U.S. as Zyloprim by Prometheus Labs and Aloprin injectables by Mylan Laboratories.